NURIX THERAPEUTICS, INC.

SAN FRANCISCO, CA How do I update this listing?

Nurix Therapeutics is based out of San Francisco. Nurix Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops novel therapies for patients who do not have adequate treatment options by controlling protein levels in cells as a new treatment approach for a broad range of diseases. Nurix Therapeutics serves patients in the State of California. The firm last filed a Form D notice of exempt offering of securities on 2020-03-26. The notice included securities offered of Equity

Create Alert

Contact Info

nurix therapeutics, inc.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO CA    94158

Business Phone: (415) 660-5320
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-03-26 D OTHER Equity 120,249,972 120,249,972 0
2015-09-18 D OTHER Equity 17,033,334 17,033,334 0
2014-01-02 D OTHER Equity 25,150,000 2,075,000 23,075,000
2013-03-28 D/A OTHER Equity 5,300,000 5,300,000 0
2012-05-16 D OTHER Equity 1,800 1,800 0
2012-05-15 D OTHER Equity 3,100,000 3,100,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARTHUR T. SANDS subscription required
    EXECUTIVE OFFICER DIRECTOR
CHRISTINE RING subscription required
    EXECUTIVE OFFICER
DAVID GOEDDEL subscription required
    DIRECTOR
DAVID LACEY subscription required
    DIRECTOR
HANS VAN HOUTE subscription required
    EXECUTIVE OFFICER
JEFF TONG subscription required
    DIRECTOR
JULIA GREGORY subscription required
    DIRECTOR
KUTZKEY TIMOTHY subscription required
    EXECUTIVE OFFICER DIRECTOR
LEON CHEN subscription required
    DIRECTOR
LORI KUNKEL subscription required
    DIRECTOR
MARK GOLDSMITH subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBERT TJIAN subscription required
    DIRECTOR
TIMOTHY KUTZKEY subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments